Keyphrases
Validation Studies
100%
Risk Assessment
100%
Scoring System
100%
Prognostic Factors
100%
Prognostic Risk Factors
100%
Chronic Myeloid Leukemia
100%
Bone Marrow Blast
100%
Prognostic Scoring System
100%
Patient Cohort
50%
Peripheral Blood
50%
Myelodysplastic Syndrome
50%
New Patients
50%
Treatment Decisions
50%
Hemoglobin
50%
Biological Characteristics
50%
Systems-based
50%
Retrospective Analysis
50%
Risk Assessment Tool
50%
Extended Follow-up
50%
Additional Guidance
50%
Lactate Dehydrogenase
50%
Optimal Therapy
50%
Absolute Lymphocyte Count
50%
International Prognostic Scoring System
50%
Medicine and Dentistry
Prognostic Factor
100%
Scoring System
100%
Chronic Myelomonocytic Leukemia
100%
Diseases
50%
Myelodysplastic Syndrome
25%
Lactate Dehydrogenase
25%
International Prognostic Scoring System
25%
Lymphocyte
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Myelomonocytic Leukemia
100%
Disease
66%
Myelodysplastic Syndrome
33%
Lactate Dehydrogenase
33%